Status:
COMPLETED
Role of Synchronized Lifestyle Modification Program in Insulin Dependent Diabetic Peripheral Neuropathy Patients
Lead Sponsor:
Riphah International University
Conditions:
Diabetic Neuropathies
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
This study aims to determine the role of Synchronized Lifestyle modification program along with Physiotherapy on the symptoms of DPN in patients on insulin therapy.
Detailed Description
Diabetes mellitus (DM) is a metabolic disorder which influence about 8.3% of adult population and is the fifth major cause of death globally. In Pakistan, prevalence of type 2 diabetes is 16.98% accor...
Eligibility Criteria
Inclusion
- Both males and females
- Five years duration of clinically diagnosed type 2 Diabetes were included in the study
- On insulin therapy
- Diagnosed to have peripheral neuropathy according to Michigan Neuropathy Screening Instrument with a physical examination score \> 2.5
Exclusion
- Type 1 Diabetics
- Type 2 Diabetics
- On oral hypoglycemic and Glucagon-like Peptide-1 analogues, patients having neuropathies due to other causes (Vitamin B₁₂ deficiency, Drug and Alcohol abuse), patients with other co-morbidities (Renal insufficiency, Heart, Liver and Eye diseases)
- Patients with foot ulcers and orthopedic or surgical problems of lower limb
- Patients with peripheral vascular diseases, inability to walk independently
- Patients receiving any structured supervised physiotherapy intervention
- Pregnant females were excluded from the study
Key Trial Info
Start Date :
February 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04813133
Start Date
February 5 2021
End Date
January 30 2022
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pakistan Railway Hospital, Islamabad
Islamabad, Federal, Pakistan, 44000